Institutional investors purchased a net $171.3 thousand shares of AMRN during the quarter ended June 2017. This may signal that the smart money is gaining interest in this company as the 37.76% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GREAT POINT PARTNERS LLC Bought 1.8 Million shares of Amarin Corporation PLC